Results 41 to 50 of about 48,129 (210)
Summary. Background: The increased life expectancy of the hemophilia population, primarily as a result of advances in factor replacement therapy, has enabled hemophiliacs to reach an older age.
Macchi S +25 more
core +1 more source
Hemophilia treatment and transfusion medicine
The improvement of hemophilia treatment is attributed to the development of transfusion medicine, and the discovery of cryoprecipitate has opened up a new era of hemophilia treatment, laying the foundation for the development of modern hemophilia ...
FANG Yunhai, CHENG Yan, ZHANG Xinsheng
doaj +1 more source
Hemophilia gene therapy knowledge and perceptions: Results of an international survey
Background Hemophilia gene therapy is a rapidly evolving therapeutic approach in which a number of programs are approaching clinical development completion.
Flora Peyvandi +8 more
doaj +1 more source
RNAi for the Treatment of People with Hemophilia: Current Evidence and Patient Selection
Sara Boyce,1 Savita Rangarajan2 1Haemophilia Comprehensive Care Centre, University Hospital Southampton, Southampton, UK; 2Faculty of Medicine, University of Southampton, Southampton, UKCorrespondence: Sara Boyce, Email sara.boyce@uhs.nhs.ukAbstract ...
Rangarajan S, Boyce S
core
Use of implantable venous access devices in children with severe hemophilia: benefits and burden
BACKGROUND AND OBJECTIVES: Since venous access in small children can be difficult to obtain, implantable venous access devices (IVAD) are used to administer clotting factor in such patients with severe hemophilia. The aim of our study was to evaluate how
K Van Dijk +4 more
doaj
An international registry of patients with plasminogen deficiency (HISTORY)
Plasminogen deficiency is an ultra-rare multisystem disorder characterized by the development of fibrin-rich pseudomembranes on mucous membranes. Ligneous conjunctivitis, which can result in vision impairment or loss, is the most frequent symptom ...
Amy D. Shapiro +9 more
doaj +1 more source
Prepared by the World Federation of Hemophilia in collaboration with the World Health Organization79 ...
World Health Organization +3 more
core
Animal Models of Hemophilia [PDF]
The X-linked bleeding disorder hemophilia is caused by mutations in coagulation factor VIII (hemophilia A) or factor IX (hemophilia B). Unless prophylactic treatment is provided, patients with severe disease (less than 1% clotting activity) typically ...
Timothy C. Nichols +11 more
core +1 more source
Hemophilia & Acquired Hemophilia A Hemophilia & Acquired Hemophilia A
Hemophilia is a ...
Tirunagari S +2 more
core
The book Hemophilia - Recent Advances covers various rapid advances being made in this field. The authors have produced state-of-the art chapters. Over some decades, management of hemophilia has progressed from episode based to prophylaxis.
core +1 more source

